What are the potential benefits of Olaparib compared to continuing chemotherapy?

This is a question you may want to discuss with your doctor regarding the Olaparib Maintenance Therapy in Metastatic Breast Cancer clinical trial (NCT05629429). Contact the study team or your healthcare provider for specific answers.

How will my eligibility for this trial be determined?

This is a question you may want to discuss with your doctor regarding the Olaparib Maintenance Therapy in Metastatic Breast Cancer clinical trial (NCT05629429). Contact the study team or your healthcare provider for specific answers.

What side effects should I expect from Olaparib?

This is a question you may want to discuss with your doctor regarding the Olaparib Maintenance Therapy in Metastatic Breast Cancer clinical trial (NCT05629429). Contact the study team or your healthcare provider for specific answers.

How often will I need to visit the clinic if I participate in this trial?

This is a question you may want to discuss with your doctor regarding the Olaparib Maintenance Therapy in Metastatic Breast Cancer clinical trial (NCT05629429). Contact the study team or your healthcare provider for specific answers.

What tests will be done to monitor my health during the trial?

This is a question you may want to discuss with your doctor regarding the Olaparib Maintenance Therapy in Metastatic Breast Cancer clinical trial (NCT05629429). Contact the study team or your healthcare provider for specific answers.

How will this treatment fit into my overall cancer care plan?

This is a question you may want to discuss with your doctor regarding the Olaparib Maintenance Therapy in Metastatic Breast Cancer clinical trial (NCT05629429). Contact the study team or your healthcare provider for specific answers.

Finding studies

Back

Olaparib Maintenance Therapy in Metastatic Breast Cancer

NCT056294293 sitesClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Olaparib Maintenance Therapy in Metastatic Breast Cancer